Department of Medicine Archive — Page 67 of 121
-
December 10, 2020
Study details early events of inflammatory response
Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis. -
December 3, 2020
Implementation research focus of symposium hosted by VUMC
One hundred ten participants from around the country attended a three-day virtual symposium hosted by Vanderbilt University Medical Center last month that explored how Implementation Research in the Learning Healthcare System can improve the quality and delivery of health care. -
December 3, 2020
Six Vanderbilt faculty elected as 2020 fellows of the AAAS
Six Vanderbilt University faculty members have been elected 2020 fellows of the American Association for the Advancement of Science, an honor bestowed upon AAAS members by their peers. -
November 23, 2020
Hot spots identified for colorectal cancer mortality rates among young women
Women diagnosed with early-onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology. -
November 18, 2020
Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer
Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. -
November 18, 2020
Collaborative Vanderbilt Lung Institute launches
-
November 18, 2020
New drug for metastatic colorectal cancer enters phase 3 trial
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.